Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
China Shineway Pharmaceutical GroupCSWYY 82 3-Year Book Growth Rate is 11.00% as of Dec. 2025, which is 12% above its 10-year median of 9.80. GuruFocus rates CSWYY with a GF Score™ of 82/100 and a GF Value™ of $16.01. The stock has 2 warning signs investors should review. Among 909 Drug Manufacturers companies, China Shineway Pharmaceutical Group ranks better than 72.83% on this metric.
During the past 12 months, China Shineway Pharmaceutical Group's average Book Value per Share Growth Rate was 11.70% per year.
During the past 3 years, the average Book Value per Share Growth Rate was 11.00% per year.
During the past 5 years, the average Book Value per Share Growth Rate was 7.40% per year.
During the past 10 years, the average Book Value per Share Growth Rate was 4.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of China Shineway Pharmaceutical Group was 68.20% per year. The lowest was -0.10% per year. And the median was 9.80% per year.
China Shineway Pharmaceutical Group (OTCPK:CSWYY) 3-Year Book Growth Rate Explanation
Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.
China Shineway Pharmaceutical Group 3-Year Book Growth Rate Related Terms
CSWYY vs ZTS: 3-Year Book Growth Rate Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, China Shineway Pharmaceutical Group's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Shineway Pharmaceutical Group 3-Year Book Growth Rate vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, China Shineway Pharmaceutical Group's 3-Year Book Growth Rate distribution charts can be found below:
* The bar in red indicates where China Shineway Pharmaceutical Group's 3-Year Book Growth Rate falls into.
China Shineway Pharmaceutical Group 3-Year Book Growth Rate Calculation
This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
What does a 3-Year Book Growth Rate of 11.00% mean?
China Shineway Pharmaceutical Group (CSWYY) has a 3-Year Book Growth Rate of 11.00% as of Dec. 2025. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for China Shineway Pharmaceutical Group and its competitors. This is 12% above median its historical median of 9.80. According to the industry distribution chart, China Shineway Pharmaceutical Group ranks #247 out of 909 companies in the Drug Manufacturers industry, placing it in the top 27.2%.
Is China Shineway Pharmaceutical Group's 3-Year Book Growth Rate too high?
China Shineway Pharmaceutical Group's current 3-Year Book Growth Rate of 11.00% is 12% above median its 10-year median of 9.80. The Drug Manufacturers industry median 3-Year Book Growth Rate is 4.80. China Shineway Pharmaceutical Group's value of 11.00% is 129.2% above this industry median. Based on the distribution chart, China Shineway Pharmaceutical Group ranks #247 out of 909 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, China Shineway Pharmaceutical Group has a GF Score™ of 82/100, reflecting its overall financial health beyond just this single metric.
How does China Shineway Pharmaceutical Group's 3-Year Book Growth Rate compare to ZTS?
According to the Drug Manufacturers industry distribution chart, China Shineway Pharmaceutical Group ranks #247 out of 909 companies for 3-Year Book Growth Rate. This puts China Shineway Pharmaceutical Group in the upper half of its industry. The industry median 3-Year Book Growth Rate is 4.80. China Shineway Pharmaceutical Group's value of 11.00% is 129.2% above this benchmark. While the company's 10-year median is 9.80 vs. the industry median of 4.80, China Shineway Pharmaceutical Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Book Growth Rate for a Drug Manufacturers company?
The median 3-Year Book Growth Rate among Drug Manufacturers companies is 4.80, based on 909 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year Book Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year Book Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China Shineway Pharmaceutical Group's current 3-Year Book Growth Rate of 11.00% is 129.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Book Growth Rate mean?
A high 3-Year Book Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for China Shineway Pharmaceutical Group and its competitors. For the Drug Manufacturers industry, the median 3-Year Book Growth Rate is 4.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Shineway Pharmaceutical Group's current 3-Year Book Growth Rate is 11.00%, which is 12% above median its own 10-year median of 9.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Shineway Pharmaceutical Group stock overvalued right now?
China Shineway Pharmaceutical Group (CSWYY) has a current 3-Year Book Growth Rate of 11.00%. The stock's GF Value™ is $16.01, compared to a current price of $19.25 — trading 20.2% above its estimated fair value. The current 3-Year Book Growth Rate is 11.00%, which is 12% above median its 10-year median of 9.80 and 129.2% above the Drug Manufacturers industry median of 4.80. China Shineway Pharmaceutical Group's overall GF Score™ is 82/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Book Growth Rate calculated?
3-Year Book Growth Rate is calculated from a company's financial statements. For China Shineway Pharmaceutical Group (CSWYY), the current 3-Year Book Growth Rate is 11.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China Shineway Pharmaceutical Group (CSWYY) Overvalued in 2026?
Based on GuruFocus' analysis, China Shineway Pharmaceutical Group stock appears to be overvalued.
The current stock price of $19.25 is trading 20.2% above its estimated GF Value™ of $16.01.
Key valuation signals for CSWYY:
3-Year Book Growth Rate: 11.00% (12% above median its 10-year median of 9.80)
GF Value™: $16.01 vs. price of $19.25 (20.2% above fair value)
Industry Position: 129.2% above the Drug Manufacturers median (#247 of 909)
No single metric tells the full story. See the CSWYY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China Shineway Pharmaceutical Group Ltd is an investment holding company. Along with its subsidiaries, it is engaged in the research, development, manufacturing, and trading of modern Chinese medicines. The company's products comprise injection, soft capsule, granule, traditional Chinese medicine formula granules, and others, of which injections generate maximum revenue for the company. Geographically, the group operates in the People's Republic of China (PRC) and Hong Kong.
82GF Score
Get the complete analysis for CSWYY
3-Year Book Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CSWYY has been successfully added to your 
